Plasma lipid concentrations during episodic occupational stress

Annals of Behavioral Medicine

Volumn 21, Issue 2, 1999, Pages 103-110

  McCann, Barbara S ^a   Benjamin, G Andrew H ^b   Wilkinson, Charles W ^b   Retzlaff, Barbara M ^b   Russo, Joan ^b   Knopp, Robert H ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; HYDROCORTISONE; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIETARY INTAKE; FEMALE; HEALTH BEHAVIOR; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; OCCUPATIONAL HAZARD; TRIACYLGLYCEROL BLOOD LEVEL; WORKLOAD;

EID: 0032827387     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02908290     Document Type: Article

References (53)

1. Hammar N, Alfredsson L, Theorell T: Job characteristics and the incidence of myocardial infarction. International Journal of Epidemiology. 1994, 23:277-284.
2. Karasek RA, Theorell T, Schwartz JE, et al: Job characteristics in relation to the prevalence of myocardial infarction in the U.S. Health Examination Survey (HES) and the Health and Nutrition Examination Survey (HANES). American Journal of Public Health. 1988, 78:910-918.
3. Murphy LR: Job dimensions associated with severe disability due to cardiovascular disease. Journal of Clinical Epidemiology. 1991, 44(2):155-166.
4. Johnson JV, Hall EM: Job strain, work place social support, and cardiovascular disease: A cross-sectional study of a random sample of the Swedish working population. American Journal of Public Health. 1988, 78:1336-1342.
5. Johnson JV, Hall EM, Theorell T: Combined effects of job strain and social isolation on cardiovascular disease morbidity and mortality in a random sample of the Swedish male working population. Scandinavian Journal of Work, Environment and Health. 1989, 15:271-279.
6. Schnall PL, Landsbergis PA, Baker D: Job strain and cardiovascular disease. Annual Review of Public Health. 1994, 15:381-411.
7. Alterman T, Shekelle RB, Vernon SW, Burau KD: Decision latitude, psychologic demand, job strain, and coronary heart disease in the Western Electric Study. American Journal of Epidemiology. 1994, 139:620-627.
8. Karasek R, Baker D, Marxer F, Ahlbom A, Theorell T: Job decision latitude, job demands, and cardiovascular disease: A prospective study of Swedish men. American Journal of Public Health. 1981, 71:694-705.
9. Brindley DN, McCann BS, Niaura R, Stoney CM, Suarez EC: Stress and lipoprotein metabolism: Modulators and mechanisms. Metabolism. 1993, 42(Suppl. 1):3-15.
10. Dimsdale JE, Herd JA: Variability of plasma lipids in response to emotional arousal. Psychosomatic Medicine. 1982, 44:413-430.
11. Niaura R, Stoney CM, Herbert PN: Lipids in psychological research: The last decade. Biological Psychology. 1992, 34:1-43.
12. McCann BS, Warnick GR, Knopp RH: Changes in plasma lipids and dietary intake accompanying shifts in perceived workload and stress. Psychosomatic Medicine. 1990, 52:97-108.
13. McCann BS, Magee MS, Broyles FC, et al: Acute psychological stress and epinephrine infusion in normolipidemic and hyperlipidemic men: Effects on plasma lipid and apoprotein concentrations. Psychosomatic Medicine. 1995, 57:165-176.
14. Friedman M, Rosenman RH, Carroll V: Changes in serum cholesterol and blood clotting time in men subjected to cyclic variation of occupational stress. Circulation. 1958, 17:852-861.
15. Niaura R, Herbert PN, Saritelli AL, et al: Lipid and lipoprotein responses to episodic occupational and academic stress. Archives of Internal Medicine. 1991, 151:2172-2179.
16. Gordon DJ, Hyde J, Trost DC, et al: Cyclic seasonal variation in plasma lipid and lipoprotein levels: The Lipid Research Clinics Coronary Primary Prevention Trial placebo group. Journal of Clinical Epidemiology. 1988, 41:679-689.
17. Råstam L, Hannan PJ, Luepker RV, et al: Seasonal variation in plasma cholesterol distributions: Implications for screening and referral. American Journal of Preventive Medicine. 1992, 8(6):360-366.
18. Lazarus RS: Psychological stress in the workplace. In Crandall R, Perrewé PL (eds), Occupational Stress: A Handbook. Washington, DC: Taylor and Francis, 1995.
19. Bohnen N, Nicolson N, Sulon J, Jolles J: Coping style, trait anxiety, and cortisol reactivity during mental stress. Journal of Psychosomatic Research. 1991, 35:141-147.
20. Hellhammer DH, Wade S: Endocrine correlates of stress vulnerability. Psychotherapy and Psychosomatics. 1993, 60:8-17.
21. Meyerhoff JL, Oleshansky MA, Mougey EH: Psychologic stress increases plasma levels of prolactin, cortisol, and POMC-derived peptides in man. Psychosomatic Medicine. 1988, 50:295-303.
22. Canner PL, Borhani NO, Oberman A, et al: The Hypertension Prevention Trial: Assessment of the quality of blood pressure measurements. American Journal of Epidemiology. 1991, 134:379-392.
23. McCann BS, Benjamin GAH, Wilkinson CW, et al: Variations in plasma lipid concentrations during examination stress. International Journal of Behavioral Medicine. 1996, 3:251-265.
24. Brantley PJ, Cocke TB, Jones GN, Goreczny AJ: The Daily Stress Inventory: Validity and effect of repeated administration. Journal of Psychopathology and Behavioral Assessment. 1988, 10:75-81.
25. Brantley PJ, Waggoner CD, Jones GN, Rappaport NB: A Daily Stress Inventory: Development, reliability, and validity. Journal of Behavioral Medicine. 1987, 10:61-74.
26. Brantley PJ, Dietz LS, McKnight GT, Jones GN, Tulley R: Convergence between the Daily Stress Inventory and endocrine measures of stress. Journal of Consulting and Clinical Psychology. 1988, 56:549-551.
27. Warnick GR: Enzymatic methods for quantification of lipoprotein lipids. Methods in Enzymology. 1986, 129:101-123.
28. Warnick GR, Benderson J, Albers JJ: Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clinical Chemistry. 1982, 28:1379-1388.
29. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry. 1972, 18:499-502.
30. Marcovina SM, Albers JJ, Henderson LO, Hannon WH: International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material. Clinical Chemistry. 1993, 39:773-781.
31. Kuhn CM: Adrenocortical and gonadal steroids in behavioral cardiovascular medicine. In Schneiderman N, Weiss SM, Kaufmann PG (eds), Handbook of Research Methods in Cardiovascular Behavioral Medicine. New York: Plenum, 1989, 185-204.
32. Schakel SF, Sievert YA, Buzzard IM: Sources of data for developing and maintaining a nutrient database. Journal of the American Dietetic Association. 1988, 88:1268-1271.
33. Jeffery RW, Folsom AR, Luepker RV, et al: Prevalence of overweight and weight loss behavior in a metropolitan adult population: The Minnesota Heart Survey experience. American Journal of Public Health. 1984, 74:349-352.
34. Kushi LH, Lew RA, Stare FJ, et al: Diet and 20-year mortality from coronary heart disease. The Ireland-Boston Diet-Heart Study. New England Journal of Medicine. 1985, 312:811-818.
35. Washburn RA, Goldfield SR, Smith KW, McKinlay JB: The validity of self-reported exercise-induced sweating as a measure of physical activity. American Journal of Epidemiology. 1990, 132:107-113.
36. Cochran WG: Sampling Techniques. New York: John Wiley, 1977.
37. Coresh J, Kwiterovich PO, Smith HH, Bachorik PS: Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. Journal of Lipid Research. 1993, 34:1687-1697.
38. Drexel H, Amann FW, Beran J, et al: Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation. 1994, 90:2230-2235.
39. Gotto AM: Hypertriglyceridemia: Risks and perspectives. American Journal of Cardiology. 1992, 70:19H-25H.
40. Rader DJ, Hoeg JM. Brewer HB: Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Annals of Internal Medicine. 1994, 120:1012-1025.
41. Genest J, McNamara JR, Ordovas JM, et al: Lipoprotein cholesterol, apolipoprotein A-I and B, and lipoprotein (a) abnormalities in men with premature coronary artery disease. Journal of the American College of Cardiology. 1992, 19:792-802.
42. Kwiterovich PO, Coresh J, Bachorik PS: Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged ≤50 years) and women (≤60 years) with coronary artery disease. American Journal of Cardiology. 1993, 71:631-639.
43. McGill DA, Talsma P, Ardlie NG: Relationship of blood cholesterol and apoprotein B levels to angiographically defined coronary artery disease in young males. Coronary Artery Disease. 1993, 4:261-270.
44. Kwiterovich PO, Coresh J, Smith HH, et al: Comparison of the plasma levels of apolipoproteins B and A-1 and other risk factors in men and women with premature coronary artery disease. American Journal of Cardiology. 1992, 69:1015-1021.
45. Bissett JK, Wyeth RP, Matts JP, Johnson JW, POSCH Group: Plasma lipid concentrations and subsequent coronary occlusion after a first myocardial infarction. American Journal of the Medical Sciences. 1993, 305:139-144.
46. Bailey JM, Bhagat RS: Meaning and measurement of stressors in the work environment: An evaluation. In Kasl SV, Cooper CL (eds), Stress and Health: Issues in Research Methodology. Chichester, Great Britain: John Wiley and Sons, 1987, 207-229.
47. Herd JA: Physiological basis for behavioral influences in arteriosclerosis. In Dembroski TM, Schmidt TH, Blümchen G (eds), Biobehavioral Basis of Coronary Heart Disease. Basel, Switzerland: Karger, 1983, 248-256.
48. Schneiderman N: Behavior, autonomie function and animal models of cardiovascular pathology. In Dembroski TM, Schmidt TH, Blümchen G (eds), Biobehavioral Basis of Coronary Heart Disease. Basel, Switzerland: Karger, 1983, 304-364.
49. van Knippenberg FC, de Haes JC: Measuring the quality of life of cancer patients: Psychometric properties of instruments. Journal of Clinical Epidemiology. 1988, 41:1043-1053.
50. Matthews KA, Cottington EM, Talbott E, Kuller LH, Siegel JM: Stressful work conditions and diastolic blood pressure among blue collar factory workers. American Journal of Epidemiology. 1987, 126:280-291.
51. Schlussel YR, Schnall PL, Zimbler M, Warren K, Pickering TG: The effect of work environments on blood pressure: Evidence from seven New York organizations. Journal of Hypertension. 1990, 8:679-685.
52. Schnall PL, Pieper C, Schwartz JE, et al: The relationship between 'job strain', workplace diastolic blood pressure, and left ventricular mass index. Results of a case-control study. Journal of the American Medical Association. 1990, 263:1929-1935.
53. Siegrist J, Peter R, Motz W, Strauer BE: The role of hypertension, left ventricular hypertrophy, and psychosocial risks in cardiovascular disease: Prospective evidence from blue-collar men. European Heart Journal. 1992, 13(Suppl. D):89-95.